Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
09/2003
09/18/2003CA2478945A1 Cyclic amides
09/18/2003CA2478936A1 Monocyclic aroylpyridinones as antiinflammatory agents
09/18/2003CA2478921A1 Novel chalcone derivatives and uses thereof
09/17/2003EP1344771A1 2-alkoxy-phenylsulphonic acid derivatives as intermediates for herbicidal sulphonylamino(thio)carbonyl compounds
09/17/2003EP1343817A2 Novel treatment
09/17/2003EP1343771A1 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors
09/17/2003EP1343753A2 Antimicrobial agents
09/17/2003EP1030852B1 Oxazolidinone derivatives and pharmaceutical compositions
09/17/2003CN1442412A Preparing method of substituted azoles
09/17/2003CN1442411A Method of continuously preparing substituted azoles
09/17/2003CN1121376C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives and matrix metalloprotease inhibitors
09/16/2003US6620941 Process for the preparation of thiazolidinedione derivatives
09/16/2003US6620815 Oxazolidinones and uses thereof
09/16/2003CA2249009C Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
09/16/2003CA2167408C Process for making hiv protease inhibitors
09/16/2003CA2068089C Method and compositions for using non-ionic contrast agents to reduce the risk of clot formulation in diagnostic procedures
09/12/2003WO2003074504A2 Process and intermediates for preparing phenylthiomethyl-thiazoles or oxazoles
09/12/2003WO2003074502A1 Method for producing substituted oxazoles
09/12/2003WO2003074495A1 Hppars activators
09/12/2003WO2003074483A1 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
09/12/2003WO2003074038A1 Methods for treating diseases related to intraocular pressure
09/12/2003WO2003073979A2 Derivatives of azaspiro compounds for the treatment of pain
09/12/2003CA2477715A1 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient
09/12/2003CA2477392A1 Methods for treating diseases related to intraocular pressure
09/11/2003US20030171621 Process for the synthesis of sphingosine
09/11/2003US20030171596 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
09/11/2003US20030171593 Process for arylating or vinylating or alkynating a nucleophilic compound
09/11/2003US20030171590 Preparation of terfenadine carboxylate metabolite and carebastine derivatives with reduced side effects
09/11/2003US20030171412 Anticancer agents; rheumatic disorders; cardiovascular disorders; imflammatory bowel disorders; Crohn's disease; antiulcer agents
09/11/2003US20030171377 Therapy for non-insulin dependent diabetes
09/11/2003US20030171373 Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation
09/11/2003US20030171331 Oxazolidinone cotherapy
09/11/2003US20030168970 Luminescent element material and luminescent element comprising the same
09/10/2003EP1342718A1 Method and reagents for n-alkylating ureides
09/10/2003EP1341776A1 Benzazolonylcarbonyl cyclohexenones and use thereof as herbicides
09/10/2003EP1341774A1 Fused heteroaromatic glucokinase activators
09/10/2003EP1341771A2 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
09/10/2003EP1341769A2 Bacterial gyrase inhibitors and uses thereof
09/10/2003EP1341753A1 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
09/10/2003EP1159237B1 Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use
09/10/2003EP0977742B1 The preparation of enantiomerically enriched oxazolones and alpha, alpha-disubstituted amino acids
09/10/2003CN1441800A Beta 3 adrenergic agonists
09/10/2003CN1440971A Vitronectin receptor antagnist, its preparation and use
09/09/2003US6617480 Molecular weight-enlarged ligands for asymmetric, homogeneously soluble hydrogenation catalysts, process for the production thereof and use
09/09/2003US6617343 Treating non-insulin-dependent diabetes mellitus
09/09/2003US6617323 Amino-substituted compounds useful as inhibitors of IMPDH enzyme
09/09/2003CA2146372C New process for the esterification of baccatine iii and 10-desacetylbaccatine iii
09/09/2003CA2031480C Acetylenes disubstituted with a heteroaromatic group and a substituted phenyl group having retinoid like activity
09/04/2003WO2003072572A1 Beta3-adrenergic receptor agonists
09/04/2003WO2003072554A1 Azole compounds
09/04/2003WO2003072553A1 N-aryl-2-oxazolidinone-5-carboxamides and their derivates and their use as antibacterials
09/04/2003WO2003072535A2 Substituted hydroxyethylamines
09/04/2003WO2003072532A1 Ester compound and medicinal use thereof
09/04/2003WO2003072102A1 Peroxisome proliferator activated receptor modulators
09/04/2003WO2003072101A1 2-methylthiazolidine-2,4-dicarboxylic acid and the salts thereof used for the treatment of neurodegenerative diseases
09/04/2003WO2003072100A1 Peroxisome proliferator activated receptor modulators
09/04/2003US20030166963 Using tertiary amine catalyst
09/04/2003US20030166697 Divalent aromatic heterocyclic compounds useful in prevention or treatment of hyperlipidemia, arteriosclerosis, diabetes mellitus, hypertension, obesity, and the like
09/04/2003US20030166690 Use of compounds for decreasing activity of hormone-sensitive
09/04/2003US20030166685 Acid derivatives of benzene useful as anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer
09/04/2003US20030166644 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
09/04/2003US20030166637 Amines such as 9-(4-(4-(benzothiazol-2-yl)-piperazin-1-yl)-butyl)-9H-fluorene-9-carboxylic acid (2,2,2-trifluoroethyl) amide, used as microsomal triglyceride transfer protein antagonists, to prevent atherosclerosis or hyperlipemia
09/04/2003CA2477607A1 Substituted hydroxyethylamines
09/04/2003CA2476316A1 Beta3-adrenergic receptor agonists
09/04/2003CA2476038A1 N-aryl-2-oxazolidinone-5-carboxamides and their derivates and their use as antibacterials
09/04/2003CA2474793A1 2-methylthiazolidine-2,4-dicarboxylic acid and the salts thereof used for the treatment of neurodegenerative diseases
09/03/2003EP1341403A1 Luminescent element material and luminescent element comprising the same
09/03/2003EP1340754A1 Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
09/03/2003EP1340743A1 Optically active amine derivative and method of synthesis
09/03/2003EP1339701A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors
09/03/2003EP0868182B1 Process for production of piperidine derivatives
09/03/2003CN1440383A PPARγ调制剂 PPARγ modulators
09/03/2003CN1439631A Substituted sulfamide (thio) carbonyl compounds
09/02/2003US6613944 Process to produce 3-carbon amino alcohol salts
09/02/2003US6613920 25-(5-propylimidazol-2-yl)-26,27-cyclo-9, 10-secocholesta-5,7,10(19),22-tetraene-1,3,24-triol; antagonizes the action of calcitriol in HL 60 cells; hyperprolifierative diseases of the skin, tumor diseases and precancerous stages
09/02/2003US6613349 Bactericides
08/2003
08/28/2003WO2003070277A1 Antipruritics
08/28/2003WO2003029169A3 Hydroxypropylamines
08/28/2003WO2003010142A3 A process for the preparation of perindopril, its analgous compounds and salts thereof using 2,5 -dioxo-oxazolidine intermediate compounds
08/28/2003US20030162979 Substituted sulphonylamino(thio)carbonyl compounds
08/28/2003US20030162786 Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G protein
08/28/2003US20030162778 Carbocyclic side chain containing metalloprotease inhibitors
08/28/2003US20030162776 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
08/27/2003EP1337218A2 Substituted felbamate derived compounds
08/27/2003EP1195375B1 Benzamide derivatives, insecticides for agricultural and horticultural use and usage thereof
08/27/2003EP1165547B1 Substituted benzoylpyrazoles as herbicides
08/27/2003EP0842157B1 Herbicidal sulphonylamino(thio)carbonyl compounds
08/27/2003EP0785927B1 Novel benzoxazoles
08/27/2003CN1438996A Bicyclic cyclohexylamines and their use NMDA receptor antogonists
08/26/2003US6610846 Heteroaromatic glucokinase activators
08/26/2003US6610696 Such as 2-(4-(2-(2-(4-(3,5-dimethyl-isoxazol-4-yl)-phenyl)-5-methyloxazol-4-yl) -ethyoxy)-phenoxy)-2-methylpropionic acid for treatment of diabetes (lowering serum triglycerides)
08/26/2003US6610482 Sequencing, fingerprinting and mapping biological macromolecules, typically biological polymers. The methods make use of a plurality of sequence specific recognition reagents which can also be used for classification of
08/26/2003US6610284 Preparation for prevention and healing of inflammation affections
08/21/2003WO2003069350A2 Small molecule modulators of apoptosis
08/21/2003WO2003068779A1 Cyclic compounds and their use as complex ligands
08/21/2003WO2003068759A1 Piperazine derivatives as anti-inflammatory agents
08/21/2003WO2003068730A1 Method for producing substituted 3-phenylamino-propane-1,2-diols
08/21/2003WO2003068226A1 2-oxazolamines and their use as 5-ht2b receptor antagonists
08/21/2003WO2002032844A8 Epothilone synthesis components iii and iv: asymmetrically substituted acyloins and acyloin derivatives, method for the production thereof and method for the production of epithilone b, d and epothilone derivatives
08/21/2003US20030158406 Enzyme inhibitor treating autoimmune diseases, Alzheimer's disease, atherosclerosis
1 ... 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 ... 210